The measurement of change in Graves' ophthalmopathy

Thyroid

Volumn 8, Issue 6, 1998, Pages 539-543

  Gorman, Colum A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENTETREOTIDE;

CLINICAL FEATURE; CONFERENCE PAPER; CONNECTIVE TISSUE; DIPLOPIA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EXTRAOCULAR MUSCLE; GRAVES DISEASE; INTRAOCULAR PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0031834399     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.539     Document Type: Conference Paper

References (26)

1. Bahn RS, Heufelder AE 1993 Mechanisms of disease: Pathogenesis of Graves' ophthalmopathy. N Engl J Med 329:1468-1475.
2. Gorman CA 1991 Clever is not enough: NOSPECS is form in search of function. Thyroid 1:353-355.
3. Classification of eye changes of Graves' disease 1992 Consensus statement of European, Latin American, Japanese, Asia Oceanian, and American Thyroid Association. Thyroid 2:235-236.
4. Tengroth BM 1955 The pressure in the orbit. Acta Ophthalmologica 33(43):7-100.
5. Frueh BR, Bartley R 1984 Graves' eye disease: Orbital compliance and other physical measurements. Trans Am Ophthalmol Soc LXXXII:539-596.
6. Mourits M, Prummel M, Wiersinga W, Koorneef L 1994 Measuring eye movements in Graves' ophthalmopathy. Ophthalmology 101:1341-1346.
7. Fitzsimons R, Fraco JW 1990 Functional scoring of the field of binocular single vision. Ophthalmology 97:33-35.
8. Musch D, Frueh BR, Landis JR 1985 The reliability of Hertel exophthalmometry. Ophthalmology 92:1177.
9. Nucci P, Brancato R, Bandello F, Alfarano R, Bianchi S 1989 Normal exophthalmometric values in children. Am J Ophthalmology 108:582-584.
10. Dejuan E, Hurley D, Sapira J 1980 Racial differences in normal values of proptosis. Arch Intern Med 140:1230.
11. Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest F 1986 Ophthalmopathy of Graves' disease: Computerized volume measurements of orbital fat and muscle. Am J Neuroradiology 7:651-656.
12. Forbes G, Gehring DG, Gorman CA, Brennan MD, Jackson IT 1985 Volume measurements of normal orbital structures by computed tomographic analysis. Am J Neuroradiology 6:419-24.
13. Feldon SE, Celina P, Saundra K, Muramatsu MS, Weiner JM 1985 Quantitative computer tomography of Graves' ophthalmopathy. Arch Ophthal 103:213-215.
14. Markl AF, Hilbertz TH, Mann K 1989 Graves' ophthalmopathy: Standardized evaluation of computed tomography examinations and magnetic resonance imaging. Dev Ophthalmol 20:38.
15. Frazier Byrne S, Gendron E, Glaser J, Feuer W, Atta H 1991 Diameter of normal extraocular muscles with echography. Am J Ophthalmopathy 112:706-712.
16. Neigel JM, Rootman J, Belkin B, et al 1988 Dysthyroid optic neuropathy. The crowded orbital apex syndrome. Ophthalmology 95:515-521.
17. Erickson B, Harris G, Lewandowski M, et al 1995 Echographic monitoring of response of extraocular muscles to irradiation of Graves' ophthalmopathy. Int J Rad Oncology Biol Phys 31:651-660.
18. Demer JL, Kerman BM 1994 Comparison of standardized echography with magnetic resonance imaging to measure extraocular muscle size. Am J Ophthalmology 118:351-361.
19. Willinsky RA, Arenson AM, Hurwitz J, Szalai J 1984 Ultrasonic B scan measurement of the extraocular muscles in Graves' orbitopathy. J Canadian Assoc Radiologists 35:171-173.
20. Otto AJ, Koofneef L, Mounts MP, Deen-van Leeuwen L 1996 Retrobulbar pressures measured during surgical decompression of the orbit. Br J Ophthalmology 80:1042-1045.
21. Utech C, Khatibnia U, Winter P, Wulle K 1995 MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy. Thyroid 5:185-193.
22. Hiromatsu Y, Kojima K, Ishisaka N, et al 1992 Role of magnetic resonance imaging in thyroid associated ophthalmopathy: Its predictive value for therapeutic outcome of immunosuppressive therapy. Thyroid 2:299-305.
23. Krassas GE, Dumas A, Pontikides N, Kaltsas T 1995 Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol 42:571-580.
24. Moncayo R, Baldissera I, Decristofero C, et al 1997 Evaluation of immunological mechanisms mediating thyroid associated ophthalmopathy by radionuclide imaging using the somatostatin analog III In-octreotide. Thyroid 7:21-29.
25. Kahaly G, Diaz M, Just M, Beyer J, Lieb W 1995 Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy. Thyroid 5:107-111.
26. Natt N, Bahn RS 1997 Cytokines in the evolution of Graves' ophthalmopathy. Autoimmunity 26:129-136.